GB1106594A - New substituted oxazolidones and oxazolidinethiones and process for their manufacture - Google Patents
New substituted oxazolidones and oxazolidinethiones and process for their manufactureInfo
- Publication number
- GB1106594A GB1106594A GB27463/66D GB2746366D GB1106594A GB 1106594 A GB1106594 A GB 1106594A GB 27463/66 D GB27463/66 D GB 27463/66D GB 2746366 D GB2746366 D GB 2746366D GB 1106594 A GB1106594 A GB 1106594A
- Authority
- GB
- United Kingdom
- Prior art keywords
- theophylline
- compositions
- propyl
- compounds
- oxazolidinethiones
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1432269A CH490405A (de) | 1965-07-09 | 1965-07-09 | Verfahren zur Herstellung von neuen Oxazolidinderivaten |
| CH962965A CH484172A (de) | 1965-07-09 | 1965-07-09 | Verfahren zur Herstellung eines neuen Oxazolidinons |
| CH1585565A CH512504A (de) | 1965-07-09 | 1965-11-17 | Verfahren zur Herstellung von neuen Oxazolidin-2-on-verbindungen |
| CH1585465A CH500216A (de) | 1965-07-09 | 1965-11-17 | Verfahren zur Herstellung von neuen Oxazolidinderivaten |
| CH505966A CH507271A (de) | 1965-07-09 | 1966-04-06 | Verfahren zur Herstellung von neuen Oxazolidin-2-thion-Verbindungen |
| CH667066 | 1966-05-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1106594A true GB1106594A (en) | 1968-03-20 |
Family
ID=27543759
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB27463/66D Expired GB1106594A (en) | 1965-07-09 | 1966-06-20 | New substituted oxazolidones and oxazolidinethiones and process for their manufacture |
| GB27462/66A Expired GB1108538A (en) | 1965-07-09 | 1966-06-20 | New oxazolidine derivatives and process for their manufacture |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB27462/66A Expired GB1108538A (en) | 1965-07-09 | 1966-06-20 | New oxazolidine derivatives and process for their manufacture |
Country Status (11)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3546231A (en) * | 1968-05-03 | 1970-12-08 | Ansul Co | Certain 2-(pyridyl-3-thiocarbamoyl-1,3-oxazolidines) |
| AR207554A1 (es) * | 1972-12-02 | 1976-10-15 | Otsuka Pharma Co Ltd | Procedimiento para producir derivados de 3-alquil-5-((3,4-dihidro-5-carbostiril)oximetil)-oxazolidinona-(2) |
| IT1109002B (it) * | 1977-09-22 | 1985-12-16 | Menarini Sas | Derivati del 2 oxazolidone e loro metodi di preparazione |
| DE3205457A1 (de) * | 1982-02-16 | 1983-08-25 | Merck Patent Gmbh, 6100 Darmstadt | Oxazolidin-2-one |
| US4461773A (en) * | 1982-09-15 | 1984-07-24 | E. I. Dupont De Nemours And Company | P-Oxooxazolidinylbenzene compounds as antibacterial agents |
| ES8503657A1 (es) * | 1983-07-06 | 1985-04-01 | Fabr Prod Quimicos Y Farmaceut | Un procedimiento para la preparacion de derivados de 3-sulfonamidopiridinas 2 -sustituidas. |
| JP2008303145A (ja) * | 2005-09-22 | 2008-12-18 | Takeda Chem Ind Ltd | Ｇｒｋ阻害剤からなる強心薬 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB834968A (en) * | 1957-08-28 | 1960-05-18 | Robins Co Inc A H | 5-o-alkoxyphenoxymethyl-2-oxazolidones |
| NL131194C (US20080094685A1-20080424-C00004.png) * | 1963-07-19 |
-
1965
- 1965-07-09 CH CH962965A patent/CH484172A/de not_active IP Right Cessation
- 1965-07-09 CH CH1432269A patent/CH490405A/de not_active IP Right Cessation
- 1965-11-17 CH CH1585565A patent/CH512504A/de not_active IP Right Cessation
-
1966
- 1966-04-06 CH CH505966A patent/CH507271A/de not_active IP Right Cessation
- 1966-06-01 US US554317A patent/US3455946A/en not_active Expired - Lifetime
- 1966-06-20 GB GB27463/66D patent/GB1106594A/en not_active Expired
- 1966-06-20 GB GB27462/66A patent/GB1108538A/en not_active Expired
- 1966-06-30 DE DE19661670358 patent/DE1670358A1/de active Pending
- 1966-06-30 DE DE19661670357 patent/DE1670357A1/de active Pending
- 1966-07-05 FR FR68139A patent/FR1503574A/fr not_active Expired
- 1966-07-08 BE BE683867D patent/BE683867A/xx unknown
- 1966-07-08 BR BR181111/66A patent/BR6681111D0/pt unknown
- 1966-07-08 AT AT658766A patent/AT266127B/de active
- 1966-07-08 AT AT636367A patent/AT269137B/de active
- 1966-07-08 DK DK354166AA patent/DK126116B/da unknown
- 1966-07-08 AT AT635867A patent/AT268276B/de active
- 1966-07-08 SE SE9370/66A patent/SE324775B/xx unknown
- 1966-07-08 DK DK354266AA patent/DK125893B/da unknown
- 1966-07-08 NL NL6609640A patent/NL6609640A/xx unknown
- 1966-07-08 SE SE9371/66A patent/SE324571B/xx unknown
- 1966-07-08 AT AT658866A patent/AT266128B/de active
- 1966-07-08 AT AT587767A patent/AT266129B/de active
- 1966-07-08 BR BR181113/66A patent/BR6681113D0/pt unknown
- 1966-07-08 AT AT587667A patent/AT266832B/de active
- 1966-07-08 NL NL6609639A patent/NL6609639A/xx unknown
- 1966-07-08 BE BE683868D patent/BE683868A/xx unknown
- 1966-07-13 FR FR76127A patent/FR5728M/fr not_active Expired
- 1966-09-13 FR FR76126A patent/FR5727M/fr not_active Expired
- 1966-09-27 FR FR77723A patent/FR6015M/fr not_active Expired
-
1967
- 1967-04-05 US US628520A patent/US3480640A/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES455979A1 (es) | Un procedimiento para preparar una purina sustituida. | |
| DE3777554D1 (de) | Adenosin-derivate und pharmazeutische zusammenstellungen, welche diese als aktiven bestandteil enthalten. | |
| HK35597A (en) | New phospholipid derivatives of nucleosides their preparation and their use as antiviral drugs | |
| WO1996013512B1 (en) | L-ribofuranosyl nucleosides | |
| ES8601965A1 (es) | Un procedimiento para la preparacion de una nueva serie de derivados de (1-piperidinilalquil)pirimidinona | |
| DE3878198D1 (de) | 11-arylsteroid-derivate. | |
| RO92300B (ro) | Procedeu de preparare a unor derivati de alfa-aril-4-(4,5-dihidro-3,5-dioxo-1,2,4-triazin-2(3h-il)-benzenacetonitrili | |
| OA08825A (fr) | Nouveaux dérivés de l'amino tétrahydro-5,6,7,8 naphto (2,3b) furanne, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. | |
| GB1106594A (en) | New substituted oxazolidones and oxazolidinethiones and process for their manufacture | |
| KR930701446A (ko) | 트리사이클릭 벤조디아제핀 유도체, 그의 제조방법 및 이를 함유하는 약제학적 조성물 | |
| KR910007655A (ko) | 치료용 뉴클레오시드 | |
| ES8801281A1 (es) | Procedimiento para la obtencion de benzo-(pirano y tiopirano)-piridinas | |
| IL78750A0 (en) | Oxothiazolidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| ES455133A1 (es) | Un procedimiento de preparacion de 17-esteres de 17-alfa-hi-droxi-gestogenos. | |
| ES2013379A6 (es) | Procedimiento para preparar 6-sulfenamido-6, sulfinamido- y 6-sulfonamido-purinas, nucleosidos de purinas y nucleotidos de purinas antitumorales. | |
| DE69431304T2 (de) | Nukleoside und nukleotide mit vergrösserten ringen | |
| US5378844B1 (en) | 8-(1-aminocycloalkyl)-1,3-dialkylxanthine derivatives preparation process and antidepressant nootropic and psychostimulant composition thereof | |
| SE8001425L (sv) | Cytostatiskt verkande lekemedel resp farmaceutiska beredningar | |
| IL83088A (en) | Substituted 3-isoquinolinols,their preparation and pharmaceutical compositions containing them | |
| ES8802034A1 (es) | Procedimiento de obtencion de nuevos derivados nitrogenados, penta o hexa ciclicos sustituidos por un radical aminado | |
| FR2444038A1 (fr) | Derives de pyrazolo(1,5-c)quinazoline utiles comme medicaments et leurs procedes de preparation | |
| JPS5259172A (en) | Preparation of uracil derivatives | |
| JPS5259168A (en) | Preparation of pyrimidines | |
| MY103900A (en) | 6-substituted 2'', 3''-dideoxynucleosides and pharmaceutical compositions | |
| KR890003678A (ko) | 부정맥 치료제 |